D2 lymphadenectomy is not only safe but necessary in the era of neoadjuvant chemotherapy

BACKGROUND: Patients with locally advanced resectable gastric cancers are increasingly offered neoadjuvant chemotherapy (NACT) following the MAGIC and REAL-2 trials. However, information on the toxicity of NACT, its effects on perioperative surgical outcomes and tumor response is not widely reported...

詳細記述

保存先:
書誌詳細
主要な著者: Shrikhande, Shailesh V, Barreto, Savio G, Talole, Sanjay D, Vinchurkar, Kumar, Annaiah, Somashekar, Suradkar, Kunal, Mehta, Shaesta, Goel, Mahesh
フォーマット: Artigo
言語:Inglês
出版事項: BioMed Central 2013
主題:
Research
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC3583696/
https://ncbi.nlm.nih.gov/pubmed/23375104
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1477-7819-11-31
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料